W e describe a PCR-based method called Amplified Methylation Polymorphism (AMP) for scanning genomes for DNA methylation changes. AMP detects tissue-specific DNA methylation signatures often representing junctions between methylated and unmethylated DNA close to intronexon junctions and/or associated with CpG islands. Identical AMP profiles are detected for healthy, young, monozygotic twins.
The importance of DNA methylation in mammalian biology has been recently highlighted by its involvement in several human diseases (Hendrich, 2000) , and the list of such diseases can be expected to rapidly expand with the discovery of new methods for detecting DNA methylation variation between individuals or tissues. To aid DNA methylation research, we have developed a PCR-based protocol called Amplified Methylation Polymorphism (AMP) that allows the rapid scanning of the methylation status of thousands of CpG and CpNpG sites in mammalian genomes. The detailed AMP protocol is provided as Supplementary Note 1. Briefly, AMP uses a single arbitrary decamer oligonucleotide primer containing the recognition sequence of a methylation-sensitive restriction enzyme (e.g., HpaII, which recognizes CCGG) to generate amplified profiles from both undigested genomic DNA and genomic DNA digested with the same methylation-sensitive enzyme. Amplification from digested template depends on the methylation status of the cytosines within, or closely linked to the amplicon (see later). The recognition sequences for the methylation-sensitive restriction enzyme are located in the middle of the oligonucleotide followed by up to four selective nucleotides extending to the 3' end (see Supplementary Table 1) . Changing any of the 3' selective nucleotides results in a completely separate set of AMP markers (AMPs) being amplified from the genome (see Supplementary Note 2).
PCR products are radiolabeled, separated on large polyacrylamide sequencing gels, and detected by autoradiography ( Figure 1 ). Paired PCRs on undigested and digested genomic DNA detect the methylation status of more than 75 loci on average for each unique oligonucleotide primer, representing at least 150 CpG or CpNpG sites around the genome. The AMP protocol is very robust, reliable and produces identical profiles on replicate DNA extractions (Figure 1a, 1d) . Using as few as 60 unique AMP primers, for example, approximately 4,500 loci around the genome (or 9,000 CpG or CpNpG sites) can be assessed for methylation status. More sensitive fluorescent labeling and detection of AMPs on microarrays of genomic DNA could enable assessment of many more loci per oligonucleotide primer and direct mapping of AMPs on genomes.
Comparison of the profiles from digested and undigested genomic DNA reveals three classes of AMPs ( Figure 1a ): digestion-resistant, digestion-sensitive, and digestion-dependent. In the case of humans and mice, ~ 90% of AMPs are digestion-resistant (amplified from both undigested and digested template), 7 to 8% are digestion-dependent (amplified from digested but not undigested template) and 1 to 2% are digestion-sensitive (amplified from undigested but not digested template). Digestion-resistant and digestion-sensitive AMPs represent methylated and unmethylated genomic DNA, respectively (Figure 1b) . The nature of digestion-dependent AMPs was initially intriguing, but we have strong cooperative genetic and molecular evidence that these markers represent a methylated amplicon sequence flanked by an unmethylated restriction site, followed by a linked sequence that inhibits amplification from undigested template (Figure 1b) 
Figure 1a
AMP detects DNA methylation variation in mammalian genomes.
Note: Comparison of AMP profiles generated from undigested (U) and HpaII-digested (H) genomic DNA reveals three classes of AMP markers: digestion-resistant (without arrows), digestion-sensitive (s) and digestion-dependent (d). Only half of the total AMP profile generated using one oligonucleotide primer on human lymphocyte DNA is shown. Identical profiles side-by-side are derived from replicate DNA extractions.
Figure 1b
Note: Models for digestion-sensitive and digestion-dependent AMPs. A single oligonucleotide primer (arrow) is used in paired PCRs on non-digested and HpaII-digested genomic DNA. Digestion-sensitive AMPs (upper panel) are amplified from undigested template, but digestion of unmethylated restriction sites (U) prevents primer annealing resulting in no amplification from digested template. Digestion-dependent AMPs (lower panel) represent a methylated amplicon sequence flanked by an unmethylated restriction site, followed by a linked sequence (i) that inhibits amplification from undigested template. Cleavage of the unmethylated restriction site (U) but not the methylated primerannealing sequences (M) allows amplification of digestion-dependent AMPs from digested template.
Figure 1c
Note: Southern analysis confirms tissue-specific DNA methylation polymorphisms between sperm (S) and lymphocytes (L) and that digestion-dependent AMP represent junctions between methylated and unmethylated DNA in the genome. E1, EcoRI site; H, HpaII site (short vertical lines on map) or HpaII digest; E1/H, EcoRI plus HpaII double digest. Ts1 (thick solid line on map) is a tissue-specific digestion-dependent AMP amplified only from HpaII-digested lymphocyte, but not sperm DNA, and it is located on the border of a CpG island. Methylation at HpaII sites was interpreted from restriction fragment sizes (1-4). The HpaII site on the left side of the amplicon (*) is methylated in lymphocytes but not in sperm, and other HpaII sites moving towards the centre of the CpG island are unmethylated in both lymphocytes and sperm (see arrow head indicating low molecular weight smear of HpaII fragments). A 10 kb fragment was also detected in lymphocyte DNA digested with HpaII but is not shown. For further information see Supplementary Note 3.
Figure 1d
Note: Three tissue-specific digestion-dependent human AMPs amplified with the Operon oligonucleotide primer I-08. Only one individual is shown for each tissue (replicate DNA extractions); however, all seven individuals analyzed for each tissue displayed these three tissue-specific DNA methylation signatures. L, lymphocytes; S, sperm, C; cerebellum.
Figure 1e
involving the amplicon and flanking DNA. Cleavage of the unmethylated restriction site removes the amplicon from the inhibitory sequence and permits amplification of digestion-dependent AMP markers. Inheritance analysis of digestion-dependent AMPs in plant mapping populations showed that the inhibitory sequence is always co-inherited with the amplicon (D.K.H., H.T.A. and B.J.C., manuscript in preparation), and Southern analysis with cloned AMPs confirmed that digestion-dependent amplicons are methylated and linked to unmethylated restriction sites (Figure 1c) . Thus, digestion-dependent AMPs detect the junctions of methylated and unmethylated DNA in the genome. AMP is more efficient than other methylation-sensitive PCR protocols (Liang et al., 2002) and non-PCR-based restriction landmark genome scanning (RLGS) (Costello et al., 2000) , but more importantly, unique features of AMP are that 7 to 8 % of amplified fragments (i.e. digestion-dependent AMPs) represent the junction between methylated and unmethylated DNA in the genome, and AMPs often map close to coding regions of genes (Table 1; see Supplementary Table 2) .
AMP detects abundant and distinct tissue-specific DNA methylation patterns in mammalian tissues (Figure 1d, 1e) . For humans, 21 separate individuals were sampled for lymphocytes, cerebellum or sperm (seven individuals for each tissue type). To assess the extent of tissue-specific DNA methylation within one mammalian individual, a mouse of the inbred strain BALBc was analyzed on replicate DNA extractions over a greater range of tissues including brain, lung, liver, kidney, spleen, heart and testis. For the human tissues, while 17 out of a total of 450 AMP markers (3%) were tissue-specific, 13 out of 32 digestiondependent AMPs (40%) varied depending on the tissue type (see Supplementary Table 3) . Similarly, for the mouse tissues, 15 out of a total of 600 (2.5%) and 13 out of 35 digestion-dependent AMPs (31%) were tissue-specific. About the same frequency of tissue-specific variation was observed for digestion-sensitive AMPs (30-40%), although this marker type is much less common in AMP profiles (see Supplementary  Table 3) .
Cloning, sequencing and mapping (see Supplementary Note 2) of nine digestion-dependent and six digestion-sensitive tissue-specific human AMPs showed that ~ 50 % map close to coding regions of genes (Table  1) . Five of the 15 tissue-specific AMPs mapped across or close to predicted intron-exon junctions, and others mapped close to 5' and 3' regions of genes. About 30% of tissue-specific AMPs also mapped to CpG islands ( Figure. 1f) , some of which were associated with predicted intron-exon junctions (Table 1) . CpG islands are regions of mammalian genomes that are usually close to or within genes, and are enriched for GC content and CpG frequency (Antequera & Bird, 1993; Bird, 1986; Gardiner-Garden & Frommer, 1987) . Except for CpG islands associated with inactive genes on the X chromo-
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Figure 1g
Note: Identical AMP profiles were detected for identical twins (T1 and T2). Only half of the AMP profile from one oligonucleotide on HpaII-digested template is shown, however, these twins had identical AMP profiles over ~ 8,000 CpG sites in the genome. Identical profiles side-by-side are derived from lymphocyte DNA extractions at 14 and 16 years of age.
Figure 1f
Note: Five out of 15 tissue-specific AMPs mapped to classical CpG islands (circled) with a GC content of about 50 % or higher and a CpG ratio greater than 0.5. Open triangles, digestion-dependent AMPs; closed triangles, digestion-sensitive AMPs. CpG ratio = [number of CpGs / (number of Cs × number of Gs)] / total number of base pairs, and GC content = [(number of Cs + number of Gs) × 100] / total number of base pairs (Gardiner-Garden & Frommer, 1987) .
some and imprinted genes (Panning & Jaenisch, 1996) , they have been generally assumed to be unmethylated in normal healthy tissues (Antequera & Bird, 1993; Costello & Vertino, 2002; Futscher et al., 2002) . Southern analysis confirmed the reliability of the AMP protocol for detecting tissue-specific DNA methylation profiles at the junction of methylated and unmethylated DNA (Figure 1c ). Southern analysis also demonstrated that depending on each individual AMP marker, either or both of the primer annealing sites need(s) to be methylated in order for amplification to occur (Figure 1c) .
We also used the AMP protocol to investigate the degree of concordance of DNA methylation patterns in lymphocyte DNA from three pairs of healthy, young, monozygotic dichorionic human twins (see Supplementary Note 4). The first pair of twins was sampled for DNA at 14 and 16 years of age, and at both ages, the twins had identical AMP profiles (including observed intensity of amplified fragments) over ~ 8,000 CpG sites. An example of AMP profiles generated from lymphocytes for this set of identical twins is shown in Figure 1g . The other two pairs of twins were only sampled at 14 years of age, and each pair of twins also had identical AMP profiles over 2,200 CpG sites.
In summary, our findings indicate stringent programming of DNA methylation patterns close to coding regions and/or in CpG islands to produce tissue-specific 'methylomes'. A future priority for our research will be to determine the relevance of our discovery to developmental regulation of transcription and alternative splicing. Despite demonstrations that defects in DNA methylation lead to developmental abnormalities and diseases (Hendrich, 2000) , the relationship between DNA methylation and developmental regulation of gene expression has been a subject of controversy (Costello & Vertino, 2002; Futscher et al., 2002; Holliday & Pugh, 1975; Riggs, 1975; Walsh and Bestor, 1999; Warnecke & Clark, 1999) . Perhaps the position of DNA methylation within CpG islands and/or close to intron-exon junctions in mammalian genomes are crucial in determining gene expression or some other important aspect of chromatin organization, in a tissue-specific manner. thanked for mouse tissues and/or discussion. Cerebellum tissue was obtained through Dr. P. Dodd and Dr. D. Innes from the NHMRC Brain Tissue Resource. We are grateful to Neuropathologists in the Brisbane Area Health Authority for providing brain tissue samples for analysis, and to the next of kin for providing informed written consent for the studies. Note: a Five out of 15 tissue-specific AMPs mapped to classical CpG islands with a GC content of about 50% or higher and a CpG ratio greater than 0.5 5 .
b AMPs mapping to within 1 kb of intron-exon junctions. d, digestion-dependent AMP; s, digestion-sensitive AMP; L, human lymphocyte DNA; C, human cerebellum DNA; S, human sperm DNA; +, DNA fragment amplified; -, DNA fragment not amplified.
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Supplementary Note 1: Amplified Methylation Polymorphism (AMP) Protocol AMP is a PCR-based protocol for detecting DNA methylation polymorphisms in genomic DNA. DNA methylation polymorphisms are detected by using oligonucleotide primers carrying recognition sequences for methylation-sensitive restriction endonucleases on genomic template undigested or digested with the corresponding enzyme. The procedure listed below is for use of the methylation-sensitive enzyme HpaII and corresponding HpaII oligonucleotide primers, but the protocol can be modified accordingly for all other methylation-sensitive enzymes with a four base pair recognition sequence (e.g. HhaI, AciI, AccII and MaeII). The HpaII recognition sequence is 5'-CCGG-3', but digestion only occurs if both cytosines are unmethylated (McCleland & Nelson, 1992) .
AMP Template Preparation
Genomic DNA was prepared from human lymphocytes and spermatozoa by using QIAamp DNA mini-kit (QIAGEN) and from human cerebellum and mouse tissues using the protocol described by Ausubel et al. (1998) . HpaII-digested template was then prepared by overnight digestion of 5.0 μg of high-quality genomic DNA using a ten-fold excess (i.e. 50 units) of methylation sensitive enzyme (e.g. HpaII). Digestion of the DNA was confirmed by separation and detection of 250 ng of digested DNA in a 0.7 % agarose gel. Digested DNA was precipitated, washed (Sambrook et al., 1989 ) and resuspended at 50 ng/μL in sterile milliQ water.
AMP PCR and Detection
Each AMP PCR contains 1x DAF buffer (10mM Tris pH8, 10m KCl, 5mM MgCl 2 ) (Caetano-Anolles et al., 1991; Waldron et al., 2002) , 1.5 units of DNA polymerase Stoffel Fragment (Applied Biosystems), 20 μM dNTPs, 1 μCi α-labelled 33 P-dATP and 5 μM of a single arbitrary decamer oligonucleotide primer containing the recognition sequences of a methylation sensitive restriction enzyme (e.g., Supplementary Table 1). AMP profiles are generated from 50 ng of genomic DNA (undigested and digested with the same methylation-sensitive enzyme). PCR cycling conditions involve a hot start (85˚C), followed by denaturation at 94˚C for 5 min, then 30 cycles of: 94˚C for 30 secs, 60 sec at each of 57˚C, 56˚C, 55˚C, 54˚C and 53˚C
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. The PCR was concluded with a
